AU8219191A - Stable aqueous drug suspensions - Google Patents

Stable aqueous drug suspensions

Info

Publication number: AU8219191A
Authority: AU; Australia
Prior art keywords: stable aqueous; aqueous drug; drug suspensions; suspensions; stable
Prior art date: 1990-06-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU82191/91A

Inventor

Milton Robert Kaplan

Catherine Sue Lamb

Chel Wing Lew

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

KALMO ENTERPRISES Inc

Original Assignee

KALMO ENTERPRISES Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-06-14

Filing date

1991-06-13

Publication date

1992-01-07

1991-06-13 Application filed by KALMO ENTERPRISES Inc filed Critical KALMO ENTERPRISES Inc

1992-01-07 Publication of AU8219191A publication Critical patent/AU8219191A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Medicinal Preparation (AREA)

AU82191/91A 1990-06-14 1991-06-13 Stable aqueous drug suspensions Abandoned AU8219191A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US53818390A	1990-06-14	1990-06-14
US538183		1990-06-14

Publications (1)

Publication Number	Publication Date
AU8219191A true AU8219191A (en)	1992-01-07

Family

ID=24145861

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU82191/91A Abandoned AU8219191A (en)	1990-06-14	1991-06-13	Stable aqueous drug suspensions

Country Status (4)

Country	Link
AU (1)	AU8219191A (en)
CA (1)	CA2085342A1 (en)
IL (1)	IL98508A0 (en)
WO (1)	WO1991019486A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5160742A (en) *	1991-12-31	1992-11-03	Abbott Laboratories	System for delivering an active substance for sustained release
SE9201930D0 (en) *	1992-06-24	1992-06-24	Astra Ab	GASTRIC ANTIBACTERIAL TREATMENT
AT403988B (en) *	1994-05-18	1998-07-27	Lannacher Heilmittel	SOLID ORAL RETARDED PREPARATION
AUPN969796A0 (en)	1996-05-07	1996-05-30	F.H. Faulding & Co. Limited	Taste masked liquid suspensions
AU719137B2 (en) *	1996-05-07	2000-05-04	Mayne Pharma International Pty Ltd	Taste masked liquid suspensions
DE19648576C2 (en) *	1996-11-23	1999-08-12	Lohmann Therapie Syst Lts	Lozenge for modified release of active substances in the gastrointestinal tract
DE19706979A1 (en) *	1997-02-21	1998-08-27	Lindopharm Gmbh	Combination preparation for oral erythromycins
US6197331B1 (en)	1997-07-24	2001-03-06	Perio Products Ltd.	Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
DE19741114C2 (en) *	1997-09-12	2002-10-24	Riemser Arzneimittel Ag	Moisture-stable and enteric drug form for fish
ID28166A (en) *	1998-05-20	2001-05-10	Liposome Co Inc	NEW PARTICULATE FORMULATION
SI20244A (en) *	1999-05-19	2000-12-31	LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.	Melt granulation
MXPA03003146A (en) *	2000-10-13	2004-12-06	Advancis Pharmaceuticals	Extended release erythromycin derivatives.
US20030018085A1 (en) *	2001-05-11	2003-01-23	Raoof Araz A.	Isostearic acid salts as permeation enhancers
US20030124196A1 (en)	2001-08-22	2003-07-03	Susan Weinbach	Pulsatile release compositions and methods for enhanced intestinal drug absorption
JP4732696B2 (en)	2002-04-09	2011-07-27	フラメル・テクノロジー	Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for modified release of the active ingredient
ES2314227T7 (en)	2002-04-09	2012-11-19	Flamel Technologies	ORAL PHARMACEUTICAL FORMULATION IN THE FORM OF A WATERPROOF SUSPENSION OF MICROCAPSULES THAT ALLOW THE MODIFIED RELEASE OF AMOXYLYCIN.
FR2843880B1 (en) *	2002-09-02	2006-06-02	Flamel Tech Sa	ORAL PHARMACEUTICAL FORMULATION AS AQUEOUS SUSPENSION OF MICROCAPSULES FOR MODIFIED AMOXICILLIN RELEASE
DE10260921A1 (en) *	2002-12-20	2004-07-01	Röhm GmbH & Co. KG	Process for coating substrates for pharmaceutical applications with a mixture of two film-forming coating agents
US20070098746A1 (en) *	2005-11-02	2007-05-03	Nichols William M	Multi-layered coating technology for taste masking
GB2569119A (en) *	2017-12-05	2019-06-12	Rainbow Valley Nutrients Ltd	An aqueous beverage containing microencapsulated food supplement

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4250166A (en) *	1977-05-27	1981-02-10	Shionogi & Co., Ltd.	Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
JPS601128A (en) *	1983-06-15	1985-01-07	Shionogi & Co Ltd	Long-acting cefaclor preparation
US4849227A (en) *	1986-03-21	1989-07-18	Eurasiam Laboratories, Inc.	Pharmaceutical compositions

1991
- 1991-06-13 CA CA002085342A patent/CA2085342A1/en not_active Abandoned
- 1991-06-13 AU AU82191/91A patent/AU8219191A/en not_active Abandoned
- 1991-06-13 WO PCT/US1991/004198 patent/WO1991019486A1/en not_active Ceased
- 1991-06-14 IL IL98508A patent/IL98508A0/en unknown

Also Published As

Publication number	Publication date
IL98508A0 (en)	1992-07-15
WO1991019486A1 (en)	1991-12-26
CA2085342A1 (en)	1991-12-15

Publication	Publication Date	Title
AU656157B2 (en)	1995-01-27	Pharmaceutical agents
AU672579B2 (en)	1996-10-10	Stable aqueous suspension of liposome
AU653734B2 (en)	1994-10-13	Substituted 4-biphenylmethoxypyridine derivatives
AU8219191A (en)	1992-01-07	Stable aqueous drug suspensions
AU644249B2 (en)	1993-12-02	Alpha-oxoacetamide derivatives
AU1802492A (en)	1992-12-24	New aqueous formulations
AU638496B2 (en)	1993-07-01	Acyl-biphenylyl-alkyl pyrimidine derivatives
AU7707591A (en)	1991-12-05	Hydroquinazoline derivatives
AU7500891A (en)	1991-10-17	Benzimidazolinone derivatives
AU6860691A (en)	1992-03-05	Azaoxindole derivatives
AU634039B2 (en)	1993-02-11	Hydantoin derivatives
AU9049391A (en)	1992-07-22	2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity
AU641748B2 (en)	1993-09-30	Electro-magnetic desensitizer
AU8033891A (en)	1992-01-30	Pyrimidine derivatives
AU6314890A (en)	1991-04-11	Novel cephalosporin derivatives
AU7825291A (en)	1991-12-12	Pyridinypiperazine derivatives
AU6245690A (en)	1991-03-21	Guanidine derivatives
AU8138991A (en)	1992-01-30	Carboxymethylcyclopropane derivatives
AU7874291A (en)	1991-12-31	Packaging-material body
AU8531891A (en)	1992-04-15	Imidazoline derivatives
AU5533594A (en)	1994-06-08	Stable aqueous liposome suspension
AU8994791A (en)	1992-06-25	Cephalosporin derivatives
AU7949691A (en)	1992-02-27	5-isothiazolamine derivatives
AU1431895A (en)	1995-06-27	Stable aqueous dipeptide suspensions
AU7083491A (en)	1991-08-08	Pyrimidin-2-ylphenylhydroxylamine derivatives